CD274 and neoplasm: Patients were stratified based on PD-L1 expression on tumor or ICs, high (≥25%) versus low (<25%); this cutoff was defined because it seemed to enrich for response, based on review of PD-L1 expression in the first 20 enrolled patients who were followed for a minimum of 12 weeks [24].